NCT06092034: A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- State
- Under way
- Phase
- Phase 2
- People
- 18 planned
- Started
- 5 Sep 2023
- Primary completion
- Jun 2028
- Arms
- RP-A501
- Results
- None posted
- 5 Sep 2023: Trial started
- 23 Oct 2023: Trial registered